In this second edition of his highly acclaimed book, Christopher P. Cannon, MD, and a team of preeminent clinical investigators have thoroughly revised and expanded every chapter to reflect the recent explosion of clinical trials on the management of acute coronary syndromes (ACS). This includes: the newer tests, such as C reactive protein; a multimarker approach to diagnosis and risk stratification; new antiplatelet agents; and combinations of thrombolytic-antithrombotic regimens. Also discussed are the latest developments in interventional cardiology, the use of cost-effectiveness in clinical trials to choose appropriate therapies, and the employment of critical pathways analysis to improve compliance with evidence-based medicine and guideline recommendations.
| ISBN-13: | 9781588291301 |
| ISBN-10: | 1588291308 |
| Publisher: | Humana |
| Publication date: | 2002-11-04 |
| Edition description: | 2003 |
| Pages: | 798 |
| Product dimensions: | Height: 10 Inches, Length: 7 Inches, Weight: 3.70817524684 Pounds, Width: 1.69 Inches |
| Author: | Christopher P. Cannon |
| Language: | en |
| Binding: | Hardcover |
Discover more books in the same category
Be the first to review this book!